Volume 2, Issue 3
Editorialp. 207-210
How to choose the correct cell line for producing your viral vaccine: what is important?
Author(s): Leo A van der Pol and Wilfried AM Bakker
Editorialp. 211-213
Are nonessential amino acids not so redundant for Chinese hamster ovary cell lines?
Author(s): Dina Fomina-Yadlin, Jeffrey T McGrew
Editorialp. 215-217
Biopharmaceutical manufacturing and flexible design: what does the future hold?
Author(s): Joseph McLaughlin, Amit Banerjee
Commentaryp. 223-226
Molecular pharming in plants and plant cell cultures: a great future ahead?
Author(s): Anneli Ritala*, Suvi T Hakkinen and Stefan Schillberg
Commentaryp. 227-235
Automated microbioreactor systems for pharmaceutical bioprocessing: profiling of seeding and induction conditions in high throughput fermentations
Author(s): Johannes Hemmerich and Frank Kensy
Review Articlep. 237-251
Manufacturing of viral vectors: part II. Downstream processing and safety aspects
Author(s): Otto-Wilhelm Merten, Matthias Schweizer, Parminder Chahal and Amine Kamen
Review Articlep. 253-266
Prediction of soluble heterologous protein expression levels in Escherichia coli from sequence-based features and its potential in biopharmaceutical process development
Author(s): XiaoFeng Dai, Wenwen Guo, Quan Long, Yankun Yang, Linda Harvey, Brian McNeil and Zhonghu Bai
Review Articlep. 267-284
Application of spectroscopic methods for monitoring of bioprocesses and the implications for the manufacture of biologics
Author(s): Nicholas R Abu-Absi*, Richard P Martel, Amanda M Lanza, Stacey J Clements, Michael CBorys and Zheng Jian Li
Review Articlep. 285-300
Ex situ online monitoring: application, challenges and opportunities for biopharmaceuticals processes
Author(s): Paul Kroll, Patrick Sagmeister, Wieland Reichelt, Lukas Neutsch, Tobias Klein & Christoph Herwig*
